$KREF
KKR Real Estate Finance Trust Inc. Stock $kref

$kref Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000163159622000012 Filed on February 08, 2022

Income Statement

Concept	2021 Q4	2021 Q3	2021
Revenue	$80.09M	$77.61M	$292.1M
YoY Change	24.25%	12.87%	8.0%
Cost Of Revenue	$30.27M	$29.83M	$114.4M
YoY Change	4.94%	3.48%	-10.1%
Gross Profit	$49.83M	$47.78M	$177.7M
YoY Change	39.89%	19.66%	24.09%
Gross Profit Margin	62.21%	61.56%	60.83%
Selling, General & Admin	$10.84M	$9.816M	$39.45M
YoY Change	22.74%	40.83%	25.25%
% of Gross Profit	21.75%	20.54%	22.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$9.058M	$12.00M	$39.83M
YoY Change	-9.78%	36.71%	4.53%
Operating Profit	$40.77M	$35.78M	$137.9M
YoY Change	59.38%	14.85%	31.18%
Interest Expense	$30.27M	$29.83M	$114.4M
YoY Change	4.96%	3.47%	-10.11%
% of Operating Profit	74.24%	83.38%	83.01%
Other Income/Expense, Net	$7.379M	$2.292M	$12.18M
YoY Change	488.44%	113.21%	851.05%
Pretax Income	$40.77M	$35.78M	$137.9M
YoY Change	40.51%	14.37%	151.54%
Income Tax	$427.0K	$106.0K	$684.0K
% Of Pretax Income	1.05%	0.3%	0.5%
Net Earnings	$40.34M	$35.67M	$137.2M
YoY Change	39.8%	14.38%	152.19%
Net Earnings / Revenue	50.37%	45.96%	46.96%
Basic Earnings Per Share	$0.59	$0.57	$2.22
Diluted Earnings Per Share	$0.59	$0.57	$2.21
COMMON SHARES
Basic Shares Outstanding	59.36M shares	55.64M shares	56.57M shares
Diluted Shares Outstanding	59.45M shares	56.01M shares	56.78M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$271.5M	$307.7M	$271.5M
YoY Change	145.02%	2.1%	145.02%
Cash & Equivalents	$271.5M	$307.7M	$271.5M
Short-Term Investments
Other Short-Term Assets	$1.400M	$700.0K	$1.400M
YoY Change	180.0%	0.0%	180.0%
Inventory
Prepaid Expenses
Receivables	$15.24M	$13.92M	$15.24M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$288.1M	$322.4M	$288.1M
YoY Change	127.41%	1.47%	127.41%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$35.54M	$34.81M	$35.54M
YoY Change	5.45%	3.91%	5.45%
Other Assets	$4.000M	$3.500M	$4.000M
YoY Change	60.0%	29.63%	60.0%
Total Long-Term Assets	$6.415B	$5.431B	$6.415B
YoY Change	32.57%	10.52%	32.57%
TOTAL ASSETS
Total Short-Term Assets	$288.1M	$322.4M	$288.1M
Total Long-Term Assets	$6.415B	$5.431B	$6.415B
Total Assets	$6.703B	$5.753B	$6.703B
YoY Change	34.99%	9.97%	34.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.121M	$365.0K	$2.121M
YoY Change	24.76%	-80.79%	24.76%
Accrued Expenses	$10.53M	$9.295M	$10.53M
YoY Change	23.85%	-13.94%	23.85%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$46.69M	$40.04M	$46.69M
YoY Change	14.71%	-4.68%	14.71%
LONG-TERM LIABILITIES
Long-Term Debt	$5.295B	$4.476B	$5.295B
YoY Change	36.49%	7.89%	36.49%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$5.295B	$4.476B	$5.295B
YoY Change	36.49%	7.89%	36.49%
TOTAL LIABILITIES
Total Short-Term Liabilities	$46.69M	$40.04M	$46.69M
Total Long-Term Liabilities	$5.295B	$4.476B	$5.295B
Total Liabilities	$5.342B	$4.516B	$5.342B
YoY Change	36.26%	7.77%	36.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$38.21M	-$47.02M
YoY Change	-41.84%	-33.36%
Common Stock	$613.0K	$556.0K
YoY Change	10.25%	0.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$61.00M	$61.00M
YoY Change	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	$1.361B	$1.235B	$1.361B
YoY Change
Total Liabilities & Shareholders Equity	$6.703B	$5.753B	$6.703B
YoY Change	34.99%	9.97%	34.99%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2021
OPERATING ACTIVITIES
Net Income	$40.34M	$35.67M	$137.2M
YoY Change	39.8%	14.38%	152.19%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$27.94M	$38.75M	$124.8M
YoY Change	17.87%	0.91%	8.46%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$967.7M	$31.48M	-$1.541B
YoY Change	-1243.8%	-82.69%	-1837.13%
Cash From Investing Activities	-$967.7M	$31.48M	-$1.541B
YoY Change	-1243.8%	-82.69%	-1836.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			-$120.7M
YoY Change			-581.67%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	904.2M	119.9M	$1.579B
YoY Change	-402.6%	-359.55%	-1083.43%
NET CHANGE
Cash From Operating Activities	27.94M	38.75M	$124.8M
Cash From Investing Activities	-967.7M	31.48M	-$1.541B
Cash From Financing Activities	904.2M	119.9M	$1.579B
Net Change In Cash	-35.55M	190.1M	$162.9M
YoY Change	-81.34%	9.22%	277.06%
FREE CASH FLOW
Cash From Operating Activities	$27.94M	$38.75M	$124.8M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001631596
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Local Phone Number LocalPhoneNumber	750-8300
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member
CY2019	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-38082
CY2021	dei	Entity Registrant Name EntityRegistrantName	KKR Real Estate Finance Trust Inc.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-2009094
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	30 Hudson Yards,
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 7500
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	New York,
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10001
CY2021	dei	City Area Code CityAreaCode	212
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	880000000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	61370732	shares
CY2021	dei	Auditor Firm AuditorFirmId	34
CY2021	dei	Auditor Name AuditorName	DELOITTE & TOUCHE LLP
CY2021	dei	Auditor Location AuditorLocation	New York, NY
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	271487000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	110832000	USD
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	6316733000	USD
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	4844534000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	22244000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	59801000	USD
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	6294489000	USD
CY2020Q4	us-gaap	Notes Receivable Net NotesReceivableNet	4784733000	USD
CY2021Q4	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	78569000	USD
CY2020Q4	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	0	USD
CY2021Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	35537000	USD
CY2020Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	33651000	USD
CY2021Q4	us-gaap	Interest Receivable InterestReceivable	15241000	USD
CY2020Q4	us-gaap	Interest Receivable InterestReceivable	15412000	USD
CY2021Q4	us-gaap	Other Assets OtherAssets	7916000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	20984000	USD
CY2021Q4	us-gaap	Assets Assets	6703239000	USD
CY2020Q4	us-gaap	Assets Assets	4965612000	USD
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	3726593000	USD
CY2020Q4	us-gaap	Line Of Credit LineOfCredit	2574747000	USD
CY2021Q4	kref	Collateralized Loan Obligations Net CollateralizedLoanObligationsNet	1087976000	USD
CY2020Q4	kref	Collateralized Loan Obligations Net CollateralizedLoanObligationsNet	810000000	USD
CY2021Q4	us-gaap	Secured Debt SecuredDebt	338549000	USD
CY2020Q4	us-gaap	Secured Debt SecuredDebt	288028000	USD
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	141851000	USD
CY2020Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	140465000	USD
CY2021Q4	us-gaap	Participating Mortgage Loans Participation Liabilities Amount ParticipatingMortgageLoansParticipationLiabilitiesAmount	0	USD
CY2020Q4	us-gaap	Participating Mortgage Loans Participation Liabilities Amount ParticipatingMortgageLoansParticipationLiabilitiesAmount	66232000	USD
CY2021Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	26589000	USD
CY2020Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	24287000	USD
CY2021Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	6627000	USD
CY2020Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	5381000	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	7521000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	4823000	USD
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	5952000	USD
CY2020Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	6243000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	5341658000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	3920206000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	0	USD
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	1852000	USD
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	65271058	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	59519754	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	61370732	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55619428	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	613000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	556000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1459959000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1169695000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38208000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-65698000	USD
CY2020Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3900326	shares
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3900326	shares
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	60999000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	60999000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1361434000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	1043554000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	147000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	0	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1361581000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1043554000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6703239000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4965612000	USD
CY2021Q4	us-gaap	Settlement Assets Current SettlementAssetsCurrent	0	USD
CY2020Q4	us-gaap	Settlement Assets Current SettlementAssetsCurrent	15900000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2300000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2021Q4	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	1500000	USD
CY2020Q4	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	900000	USD
CY2021	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	279950000	USD
CY2020	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	269188000	USD
CY2019	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	274335000	USD
CY2021	us-gaap	Interest Expense InterestExpense	114439000	USD
CY2020	us-gaap	Interest Expense InterestExpense	127312000	USD
CY2019	us-gaap	Interest Expense InterestExpense	158860000	USD
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	165511000	USD
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	141876000	USD
CY2019	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	115475000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6371000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	537000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	4568000	USD
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	5126000	USD
CY2020	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2019	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-2688000	USD
CY2021	kref	Variable Interest Entity Changein Net Assets VariableInterestEntityChangeinNetAssets	0	USD
CY2020	kref	Variable Interest Entity Changein Net Assets VariableInterestEntityChangeinNetAssets	0	USD
CY2019	kref	Variable Interest Entity Changein Net Assets VariableInterestEntityChangeinNetAssets	-1665000	USD
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	686000	USD
CY2020	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	744000	USD
CY2019	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	2453000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	12183000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1281000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5998000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14235000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14238000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10522000	USD
CY2021	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-4059000	USD
CY2020	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	50344000	USD
CY2019	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	USD
CY2021	kref	Management Fees To Affiliate ManagementFeesToAffiliate	19378000	USD
CY2020	kref	Management Fees To Affiliate ManagementFeesToAffiliate	16992000	USD
CY2019	kref	Management Fees To Affiliate ManagementFeesToAffiliate	17135000	USD
CY2021	us-gaap	Noninterest Expense Related To Performance Fees NoninterestExpenseRelatedToPerformanceFees	10273000	USD
CY2020	us-gaap	Noninterest Expense Related To Performance Fees NoninterestExpenseRelatedToPerformanceFees	6774000	USD
CY2019	us-gaap	Noninterest Expense Related To Performance Fees NoninterestExpenseRelatedToPerformanceFees	3272000	USD
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	39827000	USD
CY2020	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	88348000	USD
CY2019	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	30929000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	137867000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	54809000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	90544000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	684000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	412000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	579000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	137183000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	54397000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	89965000	USD
CY2021	kref	Preferred Stock Redemption Adjustment And Dividends Income Statement Impact PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact	11369000	USD
CY2020	kref	Preferred Stock Redemption Adjustment And Dividends Income Statement Impact PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact	844000	USD
CY2019	kref	Preferred Stock Redemption Adjustment And Dividends Income Statement Impact PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact	-527000	USD
CY2021	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	179000	USD
CY2020	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2019	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	125635000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	125635000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	53553000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	53553000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	90492000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	90492000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	90492000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.22
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.96
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.58
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.21
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.96
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.57
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56571200	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55985014	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57426912	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57426912	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56783388	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56057237	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57532490	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57532490	shares
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.72
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.72
CY2019	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.72
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1132342000	USD
CY2019	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	4106000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	518000	USD
CY2019	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.72
CY2019	us-gaap	Dividends Common Stock DividendsCommonStock	98860000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2669000	USD
CY2019	us-gaap	Increase In Carrying Amount Of Redeemable Preferred Stock IncreaseInCarryingAmountOfRedeemablePreferredStock	-1152000	USD
CY2019	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	89339000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1122018000	USD
CY2020	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	25061000	USD
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.72
CY2020	us-gaap	Dividends Common Stock DividendsCommonStock	95648000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3701000	USD
CY2020	us-gaap	Increase In Carrying Amount Of Redeemable Preferred Stock IncreaseInCarryingAmountOfRedeemablePreferredStock	158000	USD
CY2020	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	53711000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1043554000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	953000	USD
CY2021	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	147000	USD
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.72
CY2021	us-gaap	Dividends Common Stock DividendsCommonStock	98153000	USD
CY2021	kref	Participating Security Dividends Per Share Declared ParticipatingSecurityDividendsPerShareDeclared	0.43
CY2021	kref	Dividends Participating Securities DividendsParticipatingSecurities	172000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3567000	USD
CY2021	us-gaap	Increase In Carrying Amount Of Redeemable Preferred Stock IncreaseInCarryingAmountOfRedeemablePreferredStock	3274000	USD
CY2021	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	136533000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1361581000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	137183000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	54397000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	89965000	USD
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	15731000	USD
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	22327000	USD
CY2019	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	16765000	USD
CY2021	kref	Accretion Of Deferred Loan Costs And Discounts AccretionOfDeferredLoanCostsAndDiscounts	22851000	USD
CY2020	kref	Accretion Of Deferred Loan Costs And Discounts AccretionOfDeferredLoanCostsAndDiscounts	17222000	USD
CY2019	kref	Accretion Of Deferred Loan Costs And Discounts AccretionOfDeferredLoanCostsAndDiscounts	20217000	USD
CY2021	kref	Payments For Interest Paid In Kind PaymentsForInterestPaidInKind	2094000	USD
CY2020	kref	Payments For Interest Paid In Kind PaymentsForInterestPaidInKind	4232000	USD
CY2019	kref	Payments For Interest Paid In Kind PaymentsForInterestPaidInKind	0	USD
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	5126000	USD
CY2020	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2019	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-2688000	USD
CY2021	kref	Increase Decreasein Equity Method Investments IncreaseDecreaseinEquityMethodInvestments	3150000	USD
CY2020	kref	Increase Decreasein Equity Method Investments IncreaseDecreaseinEquityMethodInvestments	-2840000	USD
CY2019	kref	Increase Decreasein Equity Method Investments IncreaseDecreaseinEquityMethodInvestments	1420000	USD
CY2021	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-4059000	USD
CY2020	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	50344000	USD
CY2019	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	7427000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	5676000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	4091000	USD
CY2021	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-171000	USD
CY2020	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-893000	USD
CY2019	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-61000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1112000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	337000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-321000	USD
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1246000	USD
CY2020	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-1303000	USD
CY2019	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-830000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	621000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2029000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	122000	USD
CY2021	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	806000	USD
CY2020	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	-350000	USD
CY2019	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	167000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	124793000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	115062000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	91713000	USD
CY2021	us-gaap	Proceeds From Sale Of Trading Securities Heldforinvestment ProceedsFromSaleOfTradingSecuritiesHeldforinvestment	0	USD
CY2020	us-gaap	Proceeds From Sale Of Trading Securities Heldforinvestment ProceedsFromSaleOfTradingSecuritiesHeldforinvestment	0	USD
CY2019	us-gaap	Proceeds From Sale Of Trading Securities Heldforinvestment ProceedsFromSaleOfTradingSecuritiesHeldforinvestment	9784000	USD
CY2021	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	2362442000	USD
CY2020	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	1054891000	USD
CY2019	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	1934893000	USD
CY2021	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	3904580000	USD
CY2020	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	966182000	USD
CY2019	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	2864810000	USD
CY2021	us-gaap	Proceeds From Real Estate And Real Estate Joint Ventures ProceedsFromRealEstateAndRealEstateJointVentures	1302000	USD
CY2020	us-gaap	Proceeds From Real Estate And Real Estate Joint Ventures ProceedsFromRealEstateAndRealEstateJointVentures	0	USD
CY2019	us-gaap	Proceeds From Real Estate And Real Estate Joint Ventures ProceedsFromRealEstateAndRealEstateJointVentures	0	USD
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2020	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2019	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	6245000	USD
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	USD
CY2020	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	USD
CY2019	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	94007000	USD
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2019	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	94071000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1540836000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	88709000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-926314000	USD
CY2021	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	3641991000	USD
CY2020	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	1015430000	USD
CY2019	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	3217859000	USD
CY2021	kref	Proceeds From Issuance Of Collateralized Loan Obligation ProceedsFromIssuanceOfCollateralizedLoanObligation	1095250000	USD
CY2020	kref	Proceeds From Issuance Of Collateralized Loan Obligation ProceedsFromIssuanceOfCollateralizedLoanObligation	0	USD
CY2019	kref	Proceeds From Issuance Of Collateralized Loan Obligation ProceedsFromIssuanceOfCollateralizedLoanObligation	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	52250000	USD
CY2020	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	292500000	USD
CY2019	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	120711000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	167066000	USD
CY2020	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	95680000	USD
CY2020	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	96451000	USD
CY2019	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	98954000	USD
CY2021	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	8266000	USD
CY2020	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	634000	USD
CY2019	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	592000	USD
CY2021	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	2487673000	USD
CY2020	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1332822000	USD
CY2019	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	2284819000	USD
CY2021	kref	Repayments Of Collateralized Loan Obligations RepaymentsOfCollateralizedLoanObligations	810000000	USD
CY2021	kref	Repayments Of Collateralized Loan Obligations RepaymentsOfCollateralizedLoanObligations	810000000	USD
CY2020	kref	Repayments Of Collateralized Loan Obligations RepaymentsOfCollateralizedLoanObligations	0	USD
CY2019	kref	Repayments Of Collateralized Loan Obligations RepaymentsOfCollateralizedLoanObligations	0	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	24192000	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	12066000	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	12060000	USD
CY2021	kref	Repayments Of Loan Participations RepaymentsOfLoanParticipations	66248000	USD
CY2020	kref	Repayments Of Loan Participations RepaymentsOfLoanParticipations	0	USD
CY2019	kref	Repayments Of Loan Participations RepaymentsOfLoanParticipations	0	USD
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	647000	USD
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	157000	USD
CY2019	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1254000	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	25061000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4106000	USD
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5581000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1297000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	385000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1578981000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-160558000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	815689000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	162938000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	43213000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-18912000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	110832000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67619000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	86531000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	273770000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	110832000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67619000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	271487000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	110832000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	67619000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2283000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	273770000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	110832000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67619000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	95256000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	103405000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	146156000	USD
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	409000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	124000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	398000	USD
CY2021	kref	Loan Principal Payments Held By Servicer LoanPrincipalPaymentsHeldByServicer	0	USD
CY2020	kref	Loan Principal Payments Held By Servicer LoanPrincipalPaymentsHeldByServicer	15850000	USD
CY2019	kref	Loan Principal Payments Held By Servicer LoanPrincipalPaymentsHeldByServicer	0	USD
CY2021	us-gaap	Dividends Dividends	26561000	USD
CY2020	us-gaap	Dividends Dividends	24287000	USD
CY2019	us-gaap	Dividends Dividends	25036000	USD
CY2021	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	77516000	USD
CY2020	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	0	USD
CY2019	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	0	USD
CY2021	kref	Participating Mortgage Loans Sold Additional Funding ParticipatingMortgageLoansSoldAdditionalFunding	0	USD
CY2020	kref	Participating Mortgage Loans Sold Additional Funding ParticipatingMortgageLoansSoldAdditionalFunding	0	USD
CY2019	kref	Participating Mortgage Loans Sold Additional Funding ParticipatingMortgageLoansSoldAdditionalFunding	150880000	USD
CY2021	kref	Deconsolidation Of Variable Interest Entities DeconsolidationOfVariableInterestEntities	0	USD
CY2020	kref	Deconsolidation Of Variable Interest Entities DeconsolidationOfVariableInterestEntities	0	USD
CY2019	kref	Deconsolidation Of Variable Interest Entities DeconsolidationOfVariableInterestEntities	1047346000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— The preparation of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> financial statements and the reported amounts of revenue and expenses during the reporting period. Management makes subjective estimates to project cash flows KREF expects to receive on its investments in loans and securities as well as the related market discount rates, which significantly impacts the interest income, impairments, allowance for loan loss and fair values recorded or disclosed. The effects of COVID-19 may negatively and materially impact significant estimates and assumptions used by the Company including, but not limited to estimates of expected credit losses, valuation of our equity method investments and the fair value estimates of the Company’s assets and liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual results could materially differ from those estimates.</span>
CY2021Q4	kref	Debt Instrument Covenant Liquidity Required Cashand Cash Equivalents DebtInstrumentCovenantLiquidityRequiredCashandCashEquivalents	65600000	USD
CY2020Q4	kref	Debt Instrument Covenant Liquidity Required Cashand Cash Equivalents DebtInstrumentCovenantLiquidityRequiredCashandCashEquivalents	42600000	USD
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	2300000	USD
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	2300000	USD
CY2021Q4	kref	Interest Held At Servicer InterestHeldAtServicer	1400000	USD
CY2021Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	1400000	USD
CY2020Q4	us-gaap	Settlement Assets Current SettlementAssetsCurrent	15900000	USD
CY2020Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	500000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	3900000	USD
CY2021Q4	kref	Real Estate Owned Liability RealEstateOwnedLiability	3300000	USD
CY2021Q4	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	1500000	USD
CY2021Q4	us-gaap	Deferred Income DeferredIncome	600000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	3100000	USD
CY2020Q4	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	900000	USD
CY2020Q4	us-gaap	Deposits Deposits	800000	USD
CY2021Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.43
CY2021Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	5500000	USD
CY2021	kref	Prepayment Penalties PrepaymentPenalties	6700000	USD
CY2020	kref	Prepayment Penalties PrepaymentPenalties	0	USD
CY2021	kref	Net Accelerated Fees NetAcceleratedFees	5300000	USD
CY2020	kref	Net Accelerated Fees NetAcceleratedFees	1800000	USD
CY2021Q4	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	78600000	USD
CY2021Q4	kref	Real Estate Owned Other Assets Assumed RealEstateOwnedOtherAssetsAssumed	2000000	USD
CY2021Q4	kref	Weighted Average Loan Risk Rating WeightedAverageLoanRiskRating	2.9
CY2020Q4	kref	Weighted Average Loan Risk Rating WeightedAverageLoanRiskRating	3.1
CY2021Q4	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	78600000	USD
CY2021Q4	kref	Real Estate Owned Other Assets Assumed RealEstateOwnedOtherAssetsAssumed	2000000	USD
CY2021Q4	kref	Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateral	0.303
CY2020Q4	kref	Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateral	0.367
CY2021Q4	kref	Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral Percentageif Maximum Amountis Borrowed DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateralPercentageifMaximumAmountisBorrowed	0.259
CY2020Q4	kref	Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral Percentageif Maximum Amountis Borrowed DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateralPercentageifMaximumAmountisBorrowed	0.348
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1608173000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	511187000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	703168000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	569612000	USD
CY2021Q4	kref	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	345753000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3737893000	USD
CY2021	kref	Debt Instrument Covenant Interest Incometo Interest Expense Ratio DebtInstrumentCovenantInterestIncometoInterestExpenseRatio	1.5
CY2021	kref	Debt Instrument Covenant Consolidated Tangible Net Worth Minimum Percentageof Aggregate Cash Proceeds Madeand Capital Contributions Received DebtInstrumentCovenantConsolidatedTangibleNetWorthMinimumPercentageofAggregateCashProceedsMadeandCapitalContributionsReceived	0.750
CY2021	kref	Debt Instrument Covenant Consolidated Tangible Net Worth Amountof Aggregate Cash Proceeds Madeand Capital Contributions Received DebtInstrumentCovenantConsolidatedTangibleNetWorthAmountofAggregateCashProceedsMadeandCapitalContributionsReceived	1095400000	USD
CY2021	kref	Debt Instrument Covenant Cash Liquidity Amount DebtInstrumentCovenantCashLiquidityAmount	10000000	USD
CY2021	kref	Debt Instrument Covenant Cash Liquidity Percentof Recourse Indebtedness DebtInstrumentCovenantCashLiquidityPercentofRecourseIndebtedness	0.050
CY2021	kref	Debt Instrument Covenant Total Indebtedness Percentof Total Assets DebtInstrumentCovenantTotalIndebtednessPercentofTotalAssets	0.833
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55985014	shares
CY2021Q4	kref	Collateral Assets Under Collateralized Loan Obligations As A Percentage Of Commercial Mortgage Loans CollateralAssetsUnderCollateralizedLoanObligationsAsAPercentageOfCommercialMortgageLoans	0.196
CY2020Q4	kref	Collateral Assets Under Collateralized Loan Obligations As A Percentage Of Commercial Mortgage Loans CollateralAssetsUnderCollateralizedLoanObligationsAsAPercentageOfCommercialMortgageLoans	0.205
CY2021Q4	kref	Percentage Of Collateralized Loan Obligations Under Floating Rate Loans PercentageOfCollateralizedLoanObligationsUnderFloatingRateLoans	1
CY2020Q4	kref	Percentage Of Collateralized Loan Obligations Under Floating Rate Loans PercentageOfCollateralizedLoanObligationsUnderFloatingRateLoans	1
CY2014Q4	kref	Common Stockand Preferred Stock Shares Authorized CommonStockandPreferredStockSharesAuthorized	350000000	shares
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3900326	shares
CY2021	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2020	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	2037637	shares
CY2020	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	12.27
CY2020Q3	us-gaap	Dividends Common Stock DividendsCommonStock	23861000	USD
CY2021Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	100000000	USD
CY2020	kref	Treasury Stock Value Acquired Cost Method Net TreasuryStockValueAcquiredCostMethodNet	25000000	USD
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.43
CY2021Q1	us-gaap	Dividends Common Stock DividendsCommonStock	23916000	USD
CY2021Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.43
CY2021Q2	us-gaap	Dividends Common Stock DividendsCommonStock	23924000	USD
CY2021Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.43
CY2021Q3	us-gaap	Dividends Common Stock DividendsCommonStock	23924000	USD
CY2021Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.43
CY2021Q4	us-gaap	Dividends Common Stock DividendsCommonStock	26389000	USD
CY2021	us-gaap	Dividends Common Stock DividendsCommonStock	98153000	USD
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.43
CY2020Q1	us-gaap	Dividends Common Stock DividendsCommonStock	24010000	USD
CY2020Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.43
CY2020Q2	us-gaap	Dividends Common Stock DividendsCommonStock	23861000	USD
CY2020Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.43
CY2020Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.43
CY2020Q4	us-gaap	Dividends Common Stock DividendsCommonStock	23916000	USD
CY2020	us-gaap	Dividends Common Stock DividendsCommonStock	95648000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y2M12D
CY2021	us-gaap	Profit Loss ProfitLoss	137183000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	54397000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	89965000	USD
CY2021	kref	Preferred Stock Redemption Adjustment And Dividends Income Statement Impact PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact	11369000	USD
CY2020	kref	Preferred Stock Redemption Adjustment And Dividends Income Statement Impact PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact	844000	USD
CY2019	kref	Preferred Stock Redemption Adjustment And Dividends Income Statement Impact PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact	-527000	USD
CY2021	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	179000	USD
CY2021	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	179000	USD
CY2020	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	0	USD
CY2020	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2019	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	0	USD
CY2019	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	125635000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	125635000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	53553000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	53553000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	90492000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	90492000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	90492000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56571200	shares
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57426912	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57426912	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Accelerated Share Repurchase Agreements IncrementalCommonSharesAttributableToAcceleratedShareRepurchaseAgreements	212188	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Accelerated Share Repurchase Agreements IncrementalCommonSharesAttributableToAcceleratedShareRepurchaseAgreements	72223	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Accelerated Share Repurchase Agreements IncrementalCommonSharesAttributableToAcceleratedShareRepurchaseAgreements	105578	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56783388	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56057237	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57532490	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57532490	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.22
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.96
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.58
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.21
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.96
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.57
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	415520	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	443052	shares
CY2021Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	5952000	USD
CY2020Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	6243000	USD
CY2021	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	31202000	USD
CY2020	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	25434000	USD
CY2019	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	21876000	USD
CY2021Q2	kref	Payments For Equity Offering Discounts And Commissions PaymentsForEquityOfferingDiscountsAndCommissions	1600000	USD
CY2020Q4	us-gaap	Mortgage Loans On Real Estate Writedown Or Reserve Amount1 MortgageLoansOnRealEstateWritedownOrReserveAmount1	20500000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	700000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	400000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	600000	USD
CY2021Q4	kref	Common Stock Distributions Percentage Taxedas Ordinary Income CommonStockDistributionsPercentageTaxedasOrdinaryIncome	0.991
CY2021Q4	kref	Common Stock Distributions Percentage Taxed As Qualified Dividends CommonStockDistributionsPercentageTaxedAsQualifiedDividends	0.012
CY2021Q4	kref	Common Stock Distributions Percentage Taxedas Long Term Capital Gain CommonStockDistributionsPercentageTaxedasLongTermCapitalGain	0.009
CY2021Q4	kref	Common Stock Distributions Percentage Taxedas Returnof Capital CommonStockDistributionsPercentageTaxedasReturnofCapital	0
CY2020Q4	kref	Common Stock Distributions Percentage Taxedas Ordinary Income CommonStockDistributionsPercentageTaxedasOrdinaryIncome	1.000
CY2020Q4	kref	Common Stock Distributions Percentage Taxed As Qualified Dividends CommonStockDistributionsPercentageTaxedAsQualifiedDividends	0.008
CY2020Q4	kref	Common Stock Distributions Percentage Taxedas Long Term Capital Gain CommonStockDistributionsPercentageTaxedasLongTermCapitalGain	0
CY2020Q4	kref	Common Stock Distributions Percentage Taxedas Returnof Capital CommonStockDistributionsPercentageTaxedasReturnofCapital	0
CY2019Q4	kref	Common Stock Distributions Percentage Taxedas Ordinary Income CommonStockDistributionsPercentageTaxedasOrdinaryIncome	0.991
CY2019Q4	kref	Common Stock Distributions Percentage Taxed As Qualified Dividends CommonStockDistributionsPercentageTaxedAsQualifiedDividends	0.016
CY2019Q4	kref	Common Stock Distributions Percentage Taxedas Long Term Capital Gain CommonStockDistributionsPercentageTaxedasLongTermCapitalGain	0.009
CY2019Q4	kref	Common Stock Distributions Percentage Taxedas Returnof Capital CommonStockDistributionsPercentageTaxedasReturnofCapital	0
CY2021Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	64766000	USD
CY2021Q2	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	67149000	USD
CY2021Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	75320000	USD
CY2021Q4	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	72715000	USD
CY2021	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	279950000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	27383000	USD
CY2021Q2	us-gaap	Interest Expense InterestExpense	26958000	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	29832000	USD
CY2021Q4	us-gaap	Interest Expense InterestExpense	30266000	USD
CY2021	us-gaap	Interest Expense InterestExpense	114439000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	37383000	USD
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	40191000	USD
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	45488000	USD
CY2021Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	42449000	USD
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	165511000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1156000	USD
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1356000	USD
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2292000	USD
CY2021Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7379000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	12183000	USD
CY2021Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	8399000	USD
CY2021Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	10367000	USD
CY2021Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	12003000	USD
CY2021Q4	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	9058000	USD
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	39827000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	30140000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	31180000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	35777000	USD
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	40770000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	137867000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	48000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	103000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	106000	USD
CY2021Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	427000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	684000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	30092000	USD
CY2021Q2	us-gaap	Profit Loss ProfitLoss	31077000	USD
CY2021Q3	us-gaap	Profit Loss ProfitLoss	35671000	USD
CY2021Q4	us-gaap	Profit Loss ProfitLoss	40343000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	137183000	USD
CY2021Q1	kref	Preferred Stock Redemption Adjustment And Dividends Income Statement Impact PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact	908000	USD
CY2021Q2	kref	Preferred Stock Redemption Adjustment And Dividends Income Statement Impact PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact	1813000	USD
CY2021Q3	kref	Preferred Stock Redemption Adjustment And Dividends Income Statement Impact PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact	3682000	USD
CY2021Q4	kref	Preferred Stock Redemption Adjustment And Dividends Income Statement Impact PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact	4966000	USD
CY2021	kref	Preferred Stock Redemption Adjustment And Dividends Income Statement Impact PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact	11369000	USD
CY2021Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.52
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.52
CY2021Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2021Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2021Q4	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	179000	USD
CY2021	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	179000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	29184000	USD
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	29264000	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	31989000	USD
CY2021Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	35198000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	125635000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.53
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.57
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.22
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.52
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.57
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.59
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.21
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55619428	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55619428	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55619428	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55632322	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55637480	shares
CY2021Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59364672	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56571200	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55731061	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55731061	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55731061	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55907086	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56011243	shares
CY2021Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59453264	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56783388	shares
CY2020Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	71079000	USD
CY2020Q2	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	67219000	USD
CY2020Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	67689000	USD
CY2020Q4	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	63201000	USD
CY2020	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	269188000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	39082000	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	30563000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	28832000	USD
CY2020Q4	us-gaap	Interest Expense InterestExpense	28835000	USD
CY2020	us-gaap	Interest Expense InterestExpense	127312000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	31997000	USD
CY2020Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	36656000	USD
CY2020Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	38857000	USD
CY2020Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	34366000	USD
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	141876000	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1541000	USD
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	493000	USD
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1075000	USD
CY2020Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1254000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1281000	USD
CY2020Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	64946000	USD
CY2020Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	8147000	USD
CY2020Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	8650000	USD
CY2020Q4	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	6605000	USD
CY2020	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	88348000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-34490000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	29002000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	31282000	USD
CY2020Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	29015000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	54809000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	82000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	77000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	96000	USD
CY2020Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	157000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	412000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-34572000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	28925000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	31186000	USD
CY2020Q4	us-gaap	Profit Loss ProfitLoss	28858000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	54397000	USD
CY2020Q1	kref	Preferred Stock Redemption Adjustment And Dividends Income Statement Impact PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact	592000	USD
CY2020Q2	kref	Preferred Stock Redemption Adjustment And Dividends Income Statement Impact PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact	335000	USD
CY2020Q3	kref	Preferred Stock Redemption Adjustment And Dividends Income Statement Impact PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact	-165000	USD
CY2020Q4	kref	Preferred Stock Redemption Adjustment And Dividends Income Statement Impact PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact	82000	USD
CY2020	kref	Preferred Stock Redemption Adjustment And Dividends Income Statement Impact PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact	844000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-35164000	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	28590000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	53553000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	31351000	USD
CY2020Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	28776000	USD
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.56
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.96
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.52
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.56
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.52
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.96
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57346726	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55491937	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55491405	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57346726	shares
CY2020Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55619428	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55985014	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55504077	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55632170	shares
CY2020Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55669230	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56057237	shares

Files In Submission

Name	View Source	Status
0001631596-22-000012-index-headers.html	Edgar Link	pending
0001631596-22-000012-index.html	Edgar Link	pending
0001631596-22-000012.txt	Edgar Link	pending
0001631596-22-000012-xbrl.zip	Edgar Link	pending
a202112-exhibit1019.htm	Edgar Link	pending
a202112-exhibit1029.htm	Edgar Link	pending
a202112-exhibit1049.htm	Edgar Link	pending
a202112-exhibit1050.htm	Edgar Link	pending
a202112-exhibit211.htm	Edgar Link	pending
a202112-exhibit231.htm	Edgar Link	pending
a202112-exhibit311.htm	Edgar Link	pending
a202112-exhibit312.htm	Edgar Link	pending
a202112-exhibit321.htm	Edgar Link	pending
a202112-exhibit322.htm	Edgar Link	pending
a202112-exhibit41.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
kref-20211231.htm	Edgar Link	pending
kref-20211231.xsd	Edgar Link	pending
kref-20211231_cal.xml	Edgar Link	unprocessable
kref-20211231_def.xml	Edgar Link	unprocessable
kref-20211231_g1.jpg	Edgar Link	pending
kref-20211231_g2.jpg	Edgar Link	pending
kref-20211231_g3.jpg	Edgar Link	pending
kref-20211231_g4.jpg	Edgar Link	pending
kref-20211231_g5.jpg	Edgar Link	pending
kref-20211231_g6.jpg	Edgar Link	pending
kref-20211231_g7.jpg	Edgar Link	pending
kref-20211231_g8.jpg	Edgar Link	pending
kref-20211231_htm.xml	Edgar Link	completed
kref-20211231_lab.xml	Edgar Link	unprocessable
kref-20211231_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KREF
KKR Real Estate Finance Trust Inc. Stock $kref

2021 Q4 Form 10-K Financial Statement

#000163159622000012 Filed on February 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KREF KKR Real Estate Finance Trust Inc. Stock $kref

2021 Q4 Form 10-K Financial Statement

#000163159622000012 Filed on February 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KREF
KKR Real Estate Finance Trust Inc. Stock $kref